Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns - Looking for prognostic markers: A case report

Archives of Medical Science

Volumn 7, Issue 5, 2011, Pages 918-922

  Jozwicki, Wojciech ^a   Brozyna, Anna Aneta ^a   Walentowicz, Małgorzata ^a   Grabiec, Marek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Fibrothecomatous differentiation; Immunoprofile; Sarcomatoid differentiation

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CD56 ANTIGEN; CD99 ANTIGEN; CHORIONIC GONADOTROPIN; CISPLATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR BETA; ETOPOSIDE; FASCIN; LACTATE DEHYDROGENASE; PROTEIN BCL 2; STEM CELL FACTOR RECEPTOR; VIMENTIN; WT1 PROTEIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CASE REPORT; COLON TUMOR; FEMALE; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LAPAROTOMY; MULTIPLE CYCLE TREATMENT; SARCOMA; SMALL INTESTINE TUMOR; THECOMA; TREATMENT OUTCOME;

EID: 81555202995     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.25573     Document Type: Article

References (12)

1. Aboud E. A review of granulosa cell tumours and thecomas of the ovary. Arch Gynecol Obstet 1997; 259: 161-5. (Pubitemid 27379673)
2. Sex cord-stromal tumors of the ovary. Deavers MT, Oliva E, Nucci MR (eds). Elsevier Churchill Livingstone 2009.
3. Hosseini M, Houshmand M, Ebrahimi A. Breast cancer risk not only was not associated with CYP17/A2 allele but also was related to A1 allele. Arch Med Sci 2009; 5: 103-6.
4. Jakubik J, Gottwald L, Kukulska M, et al. Breast cancer in pregnant women: report of two cases and review of the literature. Arch Med Sci 2008; 4: 204-7.
5. Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 2005; 18 Suppl 2: S81-98. (Pubitemid 40188618)
6. McCluggage WG, Sloan JM, Boyle DD, Toner PG. Malignant fibrothecomatous tumour of the ovary: diagnostic value of anti-inhibin immunostaining. J Clin Pathol 1998; 51: 868-71. (Pubitemid 28530856)
7. Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 2005; 36: 195-201. (Pubitemid 40313577)
8. Miyoshi Y, Ando A, Egawa C, et al. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 2002; 8: 1167-71. (Pubitemid 34517654)
9. Mayo MW, Wang CY, Drouin SS, et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. Embo J 1999; 18: 3990-4003. (Pubitemid 29335852)
10. Leibl S, Bodo K, Gogg-Kammerer M, et al. Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: an immunohistochemical study. Gynecol Oncol 2006; 101: 18-23.
11. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003; 21: 2787-99. (Pubitemid 46606324)
12. Wen YH, Yee H, Goswami S, PS Shukla. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol 2009; 28: 187-92.